NL7217354A - - Google Patents
Info
- Publication number
- NL7217354A NL7217354A NL7217354A NL7217354A NL7217354A NL 7217354 A NL7217354 A NL 7217354A NL 7217354 A NL7217354 A NL 7217354A NL 7217354 A NL7217354 A NL 7217354A NL 7217354 A NL7217354 A NL 7217354A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT3283871 | 1971-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL7217354A true NL7217354A (en:Method) | 1973-06-26 |
| NL152755B NL152755B (nl) | 1977-04-15 |
Family
ID=11236012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL727217354A NL152755B (nl) | 1971-12-23 | 1972-12-20 | Werkwijze ter bereiding van een voor orale toediening geschikt geneesmiddel met anti-bacteriele werking dat rifampicine en een daarmede synergistisch werkende heterocyclische verbinding bevat en gevormd geneesmiddel, verkregen volgens deze werkwijze. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3852450A (en:Method) |
| JP (1) | JPS535381B2 (en:Method) |
| AU (1) | AU466967B2 (en:Method) |
| BE (1) | BE793253A (en:Method) |
| CA (1) | CA985628A (en:Method) |
| FR (1) | FR2164856B1 (en:Method) |
| GB (1) | GB1346710A (en:Method) |
| IE (1) | IE37080B1 (en:Method) |
| IL (1) | IL41009A (en:Method) |
| NL (1) | NL152755B (en:Method) |
| ZA (1) | ZA728947B (en:Method) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209513A (en) | 1974-02-14 | 1980-06-24 | Burroughs Wellcome Co. | Tablet formulation |
| US4033962A (en) * | 1975-06-26 | 1977-07-05 | Hoffman-La Roche Inc. | 2,4-Diamino-pyrimidine derivatives and processes |
| US4125610A (en) * | 1977-07-27 | 1978-11-14 | Bristol-Myers Company | Antibacterial compositions |
| US4762836A (en) * | 1983-02-02 | 1988-08-09 | Eli Lilly And Company | Aromatase inhibitors |
| WO1992008461A1 (en) * | 1990-11-14 | 1992-05-29 | Protos Corporation | Specific inhibition of dihydrofolate reductase and compounds therefor |
| AU2002350212A1 (en) * | 2001-11-20 | 2003-06-10 | Dana Farber Cancer Institute | Pharmaceutically active compounds and methods of use thereof |
| US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
| ES2369640T3 (es) | 2002-05-24 | 2011-12-02 | Angiotech International Ag | Composiciones y métodos para revestir implantes médicos. |
| JP7072898B2 (ja) * | 2016-08-16 | 2022-05-23 | ユニバーシティ オブ ロチェスター | ポリミキシンｂ／トリメトプリム系の治療薬を含有する医薬組成物 |
-
0
- BE BE793253D patent/BE793253A/xx not_active IP Right Cessation
-
1972
- 1972-11-15 IE IE1573/72A patent/IE37080B1/xx unknown
- 1972-12-04 AU AU49603/72A patent/AU466967B2/en not_active Expired
- 1972-12-05 IL IL41009A patent/IL41009A/xx unknown
- 1972-12-06 JP JP12234172A patent/JPS535381B2/ja not_active Expired
- 1972-12-14 US US00315107A patent/US3852450A/en not_active Expired - Lifetime
- 1972-12-19 ZA ZA728947A patent/ZA728947B/xx unknown
- 1972-12-20 NL NL727217354A patent/NL152755B/xx not_active IP Right Cessation
- 1972-12-21 GB GB5909772A patent/GB1346710A/en not_active Expired
- 1972-12-22 CA CA159,798A patent/CA985628A/en not_active Expired
- 1972-12-22 FR FR7245867A patent/FR2164856B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU4960372A (en) | 1974-06-06 |
| AU466967B2 (en) | 1975-11-13 |
| FR2164856B1 (en:Method) | 1975-10-17 |
| US3852450A (en) | 1974-12-03 |
| IL41009A0 (en) | 1973-02-28 |
| GB1346710A (en) | 1974-02-13 |
| DE2259624B2 (de) | 1975-10-23 |
| JPS535381B2 (en:Method) | 1978-02-27 |
| IL41009A (en) | 1975-12-31 |
| NL152755B (nl) | 1977-04-15 |
| JPS4868721A (en:Method) | 1973-09-19 |
| FR2164856A1 (en:Method) | 1973-08-03 |
| CA985628A (en) | 1976-03-16 |
| ZA728947B (en) | 1973-09-26 |
| DE2259624A1 (de) | 1973-06-28 |
| IE37080L (en) | 1973-06-23 |
| BE793253A (fr) | 1973-04-16 |
| IE37080B1 (en) | 1977-04-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| V1 | Lapsed because of non-payment of the annual fee | ||
| NL80 | Information provided on patent owner name for an already discontinued patent |
Owner name: LEPETIT |